170477 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
Methods for Predicting and Monitoring Cancer Patients' Response to Teatment by Measuring Myeloid Derived Suppressor Cells (MDSCs)
#302Method to identify antigen-specific immune cells
#303Methods and kits for screening transplant recipients and candidates
#304METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#305CD7 nanobodies, encoding sequence and use thereof
#306Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses Thereof
#307MULTIPLEX TP53/CEN17/B CELL GENE-PROTEIN CO-DETECTION ASSAY AND UNIQUELY SPECIFIC PROBES FOR 19q12, INSR, ATM, DLEU2, TP53, AND 13q12
#308Methods for treating cancer
#309METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#310Biomarker-based methods for aiding the diagnosis of stroke
#311Methods and compositions for diagnosis of ectopic pregnancy
#312MOLECULAR PROFILING OF IMMUNE MODULATORS
#313Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#314Peptides and combination of peptides for use in immunotherapy against various tumors
#315Human monoclonal antibodies specific for CD22
#316Peptides and combination of peptides for use in immunotherapy against various tumors
#317Peptides and combination of peptides for use in immunotherapy against various tumors
#318Risk-stratification of B-precursor acute lymphoblastic leukemia patients
#319Method for reduction of autofluorescence from biological samples
#320Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
#321METHOD AND DEVICE FOR STABILIZING OF PROTEINS
#322Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
#323Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways
#324Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies
#325Detection of platelet-derived shed CD31
#326Antibodies to MAdCAM
#327Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment
#328Humanized antibodies against CEACAM1
#329Diagnostic methods for liver disorders
#330Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#331METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#332Biomarker panel for assessment of mucosal healing
#333Biomarkers and Therapeutic Targets for Sarcoma
#334Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1
#335Method for treatment of blood tumor using anti-TIM-3 antibody
#336Methods, kits, and systems for scoring the immune response to cancer
#337Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody
#338Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
#339METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#340Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels
#341Blood analyzer and blood analysis method
#342Peptides and combination of peptides for use in immunotherapy against various tumors
#343Peptides and combination of peptides for use in immunotherapy against various tumors
#344Peptides and combination of peptides for use in immunotherapy against various tumors
#345Peptides and combination of peptides for use in immunotherapy against various tumors
#346Peptides and combination of peptides for use in immunotherapy against various tumors
#347Peptides and combination of peptides for use in immunotherapy against various tumors
#348Peptides and combination of peptides for use in immunotherapy against various tumors
#349Peptides and combination of peptides for use in immunotherapy against various tumors
#350Antibodies against PD-1 and uses thereof
#351Compositions and methods for treatment of diabetic retinopathy
#352T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use
#353Soluble CD33 for treating myelodysplastic syndromes (MDS)
#354Biomarkers for seizures
#355Pyrite shrink-film laminate as a hydroxyl radical generator
#356ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME
#357Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#358Method for aiding differential diagnosis of stroke
#359ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME
#360Methods and materials for treating renal cell carcinoma
#361RAGE AS A C1Q RECEPTOR, METHODS AND APPLICATIONS
#362Detection and treatment of autoimmune disorders
#363Hematopoietic cell phenotyping using circulating cell-free markers
#364Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 Isoforms
#365METHOD FOR SELECTING DUODENAL FLUID SAMPLE FOR DETECTING PANCREATIC DISEASE MARKER AND METHOD FOR DETECTING PANCREATIC DISEASE MARKER
#366Predictive biomarker for cancer therapy
#367Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies
#368Anti-CEACAM5 antibodies and uses thereof
#369Identification of protein associated with hepatocellular carcinoma, gliobastoma and lung cancer
#370Method of isolating circulating tumor cells
#371Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
#372Methods for Predicting Cardiovascular Mortality Risk
#373BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#374IN VITRO SYSTEM FOR GENERATION OF ANTIGEN-SPECIFIC IMMUNE RESPONSES
#375BIOMARKERS FOR PREDICTING RESPONSE OF DLBCL TO TREATMENT WITH A BTK INHIBITOR
#376Biomarkers and methods for measuring and monitoring inflammatory disease activity
#377Treatment of peripheral T cell lymphoma
#378Non-human animals having a humanized programmed cell death 1 gene
#379THERAPEUTIC AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE
#380Antibody binding specifically to human and mouse L1CAM protein, and use therefor
#381IN VITRO METHOD FOR THE DIAGNOSIS AND SURVEILLANCE OF CANCER
#382MCAM as a biomarker for fluid homeostasis
#383Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#384KIR3DL2 binding agents
#385Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#386BIOMARKERS FOR OVARIAN CANCER
#387ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
#388Isolated cardiac stem cells and methods of their use
#389Characterization of cancer using detection of activated leukocyte cell adhesion molecule (ALCAM) shedding
#390ISOLATION AND CHARACTERIZATION OF MUSCLE REGENERATING CELLS
#391Brown adipocyte progenitors in human skeletal muscle
#392KIR3DL2 binding agents
#393ISOLATION OF CELLS AND BIOLOGICAL SUBSTANCES USING BUOYANT MICROBUBBLES
#394EpCAM aptamer for detection of cancer stem cells
#395Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use
#396METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#397PARALLEL ANALYSIS OF SERUM EPCAM AND MMP7 TO DISCRIMINATE SEPSIS, NECROTIZING ENTEROCOLITIS AND NORMAL CONTROL PATIENTS
#398Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
#399Renal Cell Carcinoma Biomarkers and Uses Thereof
#400CANCER PROGNOSTIC ASSAYS
#401C10RF32 antibodies, and uses thereof for treatment of cancer
#402PD-1 specific antibodies and uses thereof
#403Method for diagnosis of pulmonary involvement in systemic sclerosis
#404Detection of platelet-derived shed CD31
#405Methods and Compositions for hte Diagnosis and Treatment of Thyroid Cancer
#406ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#407Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same
#408MSC surface marker
#409Biomarkers for Tuberculosis and HIV/AIDS
#410B7-H3L cell surface antigen and antibodies that bind thereto
#411Method to detect the onset and to monitor the recurrence of chronic graft versus host disease in transplantation patients
#412Methods and compositions for detection of cancer
#413Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#414PVRL4 (Nectin4) is a receptor for measles virus
#415Biomarkers associated with nephropathy
#416Function homology screening
#417Renal Cell Carcinoma Biomarkers and Uses Thereof
#418DIAGNOSTIC AND THERAPEUTIC USES OF SOLUBLE FC-EPSILON RECEPTOR I FOR IGE-MEDIATED DISORDERS
#419Treatment of neuroinflammatory conditions using antibodies directed against MCAM
#420NOVEL PLATELET ACTIVATION MARKER AND METHOD FOR DETERMINATION THEREOF
#421METHOD OF DETECTING RAW PORK AND DETECTION KIT THEREFOR
#422BIOMARKERS FOR ASSESSING SIALIC ACID DEFICIENCIES
#423Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
#424Treating non-hematopoietic cancer with interleukin 6
#425MCAM as a biomarker for fluid homeostasis
#426Methods and materials for treating renal cell carcinoma and glioblastoma multiforme
#427BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#428Methods and compositions for diagnosis of ectopic pregnancy
#429Methods for Monitoring Allograft Rejection
#430Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
#431CD19-LIGAND AND USE
#432DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#433DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DEMYELINATING DISEASES
#434ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#435Methods for Predicting Cardiovascular Mortality Risk
#436Anti CEACAM1 antibodies and methods of using same
#437Method for treatment of blood tumor using anti-TIM-3 antibody
#438METHODS FOR DETECTING ENDOMETRIOSIS
#439DIAGNOSTIC METHODS FOR LIVER DISORDERS
#440Methods of killing myeloma stem and precursor cells by administering anti-CD48 antibodies
#441Inhibiting non-hematopoietic cancer with interleukin 6
#442NECTIN-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS
#443METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF THYROID CANCER
#444Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion
#445Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways
#446New Therapeutic and Diagnostic Methods for Alzheimer's Disease
#447Methods of screening for and treating autism spectrum disorders and compositions for same
#448Methods and Devices for Detecting Kidney Transplant Rejection
#449PD-1 specific antibodies and uses thereof
#450Methods and compositions for the detection of cancer
#451Biomarkers and methods for measuring and monitoring inflammatory disease activity
#452BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#453Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
#454Biomarkers associated with nephropathy
#455BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#456Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
#457Devices for Detecting Renal Disorders
#458Methods and Devices for Detecting Kidney Damage
#459Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#460Computer Methods and Devices for Detecting Kidney Damage
#461Methods and devices for detecting obstructive uropathy and associated disorders
#462Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#463Tumor microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors
#464Human monoclonal antibodies specific for CD22
#465MCAM modulation and uses thereof
#466Determining whether a test compound modulates PD-1 activity in activated immune cells using gene expression profiles
#467Use of KIR genes for predicting response to therapy
#468Anti-estrogen and immune modulator combinations for treating breast cancer
#469DETECTION OF FRAGMENTS OF NECTIN-1 FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#470Methods and kits for screening transplant recipients and candidates
#471ANTIBODIES AND OTHER LIGANDS DIRECTED AGAINST KIR2DL4 RECEPTOR FOR PRODUCTION OF INTERFERON GAMMA
#472IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES
#473IMMUNOASSAY INVOLVING MUTANT ANTIGENS TO REDUCE UNSPECIFIC BINDING
#474AGER-peptides and use thereof
#475BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#476Use of Hepatitis B X-Interacting Protein (HBXIP) in Modulation of Apoptosis
#477Making a prognosis in cases of cardiac disease using a combination of markers
#478S100A9 interaction screening method
#479Chemotaxis diagnostic
#480Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
#481METHOD FOR PREDICTION OF THE EFFICACY OF VASCULARIZATION INHIBITOR
#482COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION
#483Method for promoting immune response comprising inhibiting CD22 function in B cells
#484Hematopoietic cell phenotyping using circulating cell-free markers
#485Methods of detection GPVI
#486Monoclonal antibody to CD166 and method for production thereof
#487Marker for stem cells
#488IDENTIFICATION OF PROTEIN ASSOCIATED WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
#489B7-H3L cell surface antigen and antibodies that bind thereto
#490Compositions and methods for treatment of diabetic retinopathy
#491Detection and treatment of autoimmune disorders
#492METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS
#493Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
#494ASSESSING COLORECTAL CANCER BY MEASURING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN
#495Methods to identify compounds that modulate rage
#496Nectin 4 (N4) as a Marker for Cancer Prognosis
#497Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
#498Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
#499Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
#500Antibodies to MAdCAM
#501FUNCTION HOMOLOGY SCREENING
#502FUNCTION HOMOLOGY SCREENING
#503Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis
#504Methods for Diagnosis of Acute Myeloid Leukemia
#505Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
#506Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
#507Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
#508Methods of upmodulating an immune response with non-activating forms of B7-4
#509Antibodies to MAdCAM
#510Fluorescence polarization assay
#511Methods and kits for the detection of prion diseases
#512Hematopoietic cell phenotyping using free circulating cellular markers
#513Methods for detecting and confirming minimal disease
#514Methods for detecting vasculopathies and tumors
#515Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
#516Diagnostic and prognostic compounds and method
#517Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
#518Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
#519Methods to identify compounds that modulate rage
#520Quantitation of endothelial microparticles
#521Biomarkers for age-related macular degeneration (AMD)
#522Human antibodies that bind human MAdCAM
#523Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
#524Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
#525Diagnostic device using GP40
#526TREM-1 splice variant for use in modifying immune responses
#527Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
#528Methods for diagnosing dementia-related neurological disorders
#529Anti-CD79B protein monoclonal antibody, products containing the same, and uses thereof
#530Analyte detection
#531Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same